Conclusions Trop-2 protein overexpression is significantly associated with higher tumor grade and serves as an independent prognostic factor for DFS in endometrioid endometrial cancer.

2,3 Efficacy findings from the KEYNOTE-868/NRG- GY018 trial (NCT03914612) led to the FDA’s approval of pembrolizumab for endometrial carcinoma. The trial stratified ... advanced high-grade epithelial ...

All cases underwent diagnostic hysteroscopy followed by chromohysteroscopy using 2% methylene blue dye ... postmenopausal bleeding but it did not increase the diagnosis of endometrial carcinoma. In ...

Approximately 90% of patients diagnosed with endometrial cancer present with complaints of irregular or postmenopausal vaginal bleeding. However, this symptom is not specific and can also occur ...

Therapeutic options for patients with advanced gastric or gastro-oesophageal junction adenocarcinomas are rapidly evolving.1 Although chemotherapy alone results in a median survival of less than a ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

sacituzumab tirumotecan (SKB-264) is under development for the treatment of ovarian epithelial cancer, gastric adenocarcinoma, triple negative breast cancer, endometrial carcinoma, HER2 negative ...

As the many leaks and rumors suggested, Nintendo Switch 2 is the name of the company’s new hardware, and while it shares plenty in common with its predecessor, there are some big design upgrades ...

Morphological profiling allows accurate identification of cell types in dense iPSC-derived cultures, allowing its use for quality control and differentiation monitoring.

Nintendo finally unveils the Switch 2 console confirming features like magnetic Joy-Cons and an optical sensor. The official trailer also confirms backward compatibility with Switch games and ...